Literature DB >> 12880311

Sesquiterpenoid derivatives from Gonospermum elegans and their cytotoxic activity for HL-60 human promyelocytic cells.

Jorge Triana1, Mariana López, Milagros Rico, Javier González-Platas, José Quintana, Francisco Estévez, Francisco León, Jaime Bermejo.   

Abstract

Four new compounds, a sesquiterpene, eleganodiol (1), and three sesquiterpene lactones, eleganolactone A (2), eleganolactone B (3), and elegain (4), were isolated from Gonospermum elegans along with 16 known compounds. The structures of 1, 2, and 4 were determined on the basis of MS and NMR studies of their acetate derivatives (1a, 2a, 4a). The structure of the acetate derivative (3a) of 3 was determined on the basis of spectroscopic data interpretation and by single-crystal X-ray diffraction. Compounds 2a and 3a were used to study their biological activities on the HL-60 human promyelocytic leukemia cell line. These compounds induced morphological changes and internucleosomal DNA fragmentation characteristic of apoptotic cell death.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12880311     DOI: 10.1021/np020390y

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  3 in total

1.  Evaluation of Antioxidant and Cytotoxic Activity of Hydro-Ethanolic Extracts Obtained from Steiractinia aspera Cuatrec.

Authors:  Laura Gamboa-Carvajal; Carlos Jara-Gutiérrez; Joan Villena; Lautaro Taborga; Jairo René Martínez; Luis Espinoza; Elena E Stashenko
Journal:  Molecules       Date:  2022-06-29       Impact factor: 4.927

2.  Toward an integrated route to the vernonia allenes and related sesquiterpenoids.

Authors:  Da Xu; Michael A Drahl; Lawrence J Williams
Journal:  Beilstein J Org Chem       Date:  2011-07-05       Impact factor: 2.883

Review 3.  Potential anti-cancer activities and mechanisms of costunolide and dehydrocostuslactone.

Authors:  Xuejing Lin; Zhangxiao Peng; Changqing Su
Journal:  Int J Mol Sci       Date:  2015-05-13       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.